ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials
Thursday, March 24, 2022
Submitted by
Source
Source Name: tctMD
Several surgical associations have given a new statement in response to the new Valve Academic Research Consortium (VARC) definitions for aortic valve clinical studies. They took issue with a few things, most notably, rehospitalization, bleeding, and myocardial infarction.
Printer-friendly
